//
Clark, C - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2019
Therapeutic Area
Disease
Drug/Treatment
N/A
N/A
N/A
Faconti, L - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2019
Therapeutic Area
Disease
Drug/Treatment
N/A
N/A
Nifedipine
Oliver-Williams, C - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2019
Therapeutic Area
Disease
Drug/Treatment
Cardiovascular (CVS)
Pregnancy-Induced Hypertension
N/A
Pengo, M - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2019
Therapeutic Area
Disease
Drug/Treatment
Central Nervous System (CNS)
Sleep apnoea
N/A
Kario, K - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2019
Therapeutic Area
Disease
Drug/Treatment
N/A
N/A
N/A
McDonnell, B - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2019
Therapeutic Area
Disease
Drug/Treatment
Cardiovascular (CVS)
Hypertension
N/A
Solares, J.R. Ayala - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2019
Therapeutic Area
Disease
Drug/Treatment
Cardiovascular (CVS)
Transient Ischemic Attack
N/A
Pinho-Gomes, A.C.P - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2019
Therapeutic Area
Disease
Drug/Treatment
Cardiovascular (CVS)
Congestive heart failure
N/A
Gingles, C - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2019
Therapeutic Area
Disease
Drug/Treatment
Cardiovascular (CVS)
Left ventricular hypertrophy
Allopurinol
Giudici, A - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2019
Therapeutic Area
Disease
Drug/Treatment
Cardiovascular (CVS)
Dyslipidemia
N/A
DElia, L - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2019
Therapeutic Area
Disease
Drug/Treatment
N/A
N/A
N/A
Currie, G - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2019
Therapeutic Area
Disease
Drug/Treatment
Urology
Diabetic nephropathy
Angiotensin II
McManus, R - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2019
Therapeutic Area
Disease
Drug/Treatment
Cardiovascular (CVS)
Myocardial infarction
N/A
Kyriakoulis, K - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2019
Therapeutic Area
Disease
Drug/Treatment
Cardiovascular (CVS)
Masked hypertension
N/A
Dowsett, L - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2019
Therapeutic Area
Disease
Drug/Treatment
N/A
N/A
Nitric oxide
Pazoki, R - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2019
Therapeutic Area
Disease
Drug/Treatment
N/A
N/A
N/A
Timasheva, Yu - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2019
Therapeutic Area
Disease
Drug/Treatment
Cardiovascular (CVS)
Hypertension
N/A
Siddiqui, M - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2019
Therapeutic Area
Disease
Drug/Treatment
Cardiovascular (CVS)
Refractory hypertension
N/A
Weber, T - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2019
Therapeutic Area
Disease
Drug/Treatment
N/A
N/A
N/A
Lobo, M - European Meeting on Hypertension and Cardiovascular Protection (ESH) , 2019
Therapeutic Area
Disease
Drug/Treatment
N/A
N/A
N/A